Elucidating opportunities and pitfalls in the treatment of experimental traumatic brain injury to optimize and facilitate clinical translation
Authorde la Tremblaye, Patricia B.
O’Neil, Darik A.
LaPorte, Megan J.
Cheng, Jeffrey P.
Beitchman, Joshua A.
Thomas, Theresa Currier
Bondi, Corina O.
Kline, Anthony E.
AffiliationUniv Arizona, Coll Med, Dept Child Hlth
KeywordsAntiepileptic drugs (AEDs)
Antipsychotic drugs (APDs)
Controlled cortical impact (CCI)
Fluid percussion (FP) injury
Morris water maze (MWM)
Traumatic brain injury (TBI)
MetadataShow full item record
PublisherPERGAMON-ELSEVIER SCIENCE LTD
CitationPatricia, B., O’Neil, D. A., LaPorte, M. J., Cheng, J. P., Beitchman, J. A., Thomas, T. C., ... & Kline, A. E. (2017). Elucidating opportunities and pitfalls in the treatment of experimental traumatic brain injury to optimize and facilitate clinical translation. Neuroscience & Biobehavioral Reviews.
Rights© 2017 Elsevier Ltd. All rights reserved.
Collection InformationThis item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at email@example.com.
AbstractThe aim of this review is to discuss the research presented in a symposium entitled "Current Progress in characterizing therapeutic strategies and challenges in experimental CNS injury" which was presented at the 2016 International Behavioral Neuroscience Society annual meeting. Herein we discuss diffuse and focal traumatic brain injury (TBI) and ensuing chronic behavioral deficits as well as potential rehabilitative approaches. We also discuss the effects of stress on executive function after TBI as well as the response of the endocrine system and regulatory feedback mechanisms. The role of the endocannabinoids after CNS injury is also discussed. Finally, we conclude with a discussion of antipsychotic and antiepileptic drugs, which are provided to control TBI-induced agitation and seizures, respectively. The review consists predominantly of published data.
Note18 month embargo; published online: 30 May 2017
VersionFinal accepted manuscript
SponsorsNational Institutes of Health [HD069620, HD069620-S1, NS060005, NS084967, NS094950, NS099683]; University of Pittsburgh Physicians/UPMC Academic Foundation; Arizona Biomedical Research Commission through Arizona Department of Health Services [ADHS14-00003606]; Valley Research Partnership Awards [P2201607, P1201607]; Phoenix Children's Hospital Mission Support Funds
- Relative to Typical Antipsychotic Drugs, Aripiprazole Is a Safer Alternative for Alleviating Behavioral Disturbances After Experimental Brain Trauma.
- Authors: Phelps TI, Bondi CO, Mattiola VV, Kline AE
- Issue date: 2017 Jan
- Intermittent treatment with haloperidol or quetiapine does not disrupt motor and cognitive recovery after experimental brain trauma.
- Authors: Weeks JJ, Carlson LJ, Radabaugh HL, de la Tremblaye PB, Bondi CO, Kline AE
- Issue date: 2018 Mar 15
- Spontaneous recovery after controlled cortical impact injury is not impeded by intermittent administration of the antipsychotic drug risperidone.
- Authors: Carlson LJ, Bao GC, Besagar S, Leary JB, Radabaugh HL, Bondi CO, Kline AE
- Issue date: 2018 Aug 24
- Spontaneous recovery of traumatic brain injury-induced functional deficits is not hindered by daily administration of lorazepam.
- Authors: Cheng JP, Leary JB, O'Neil DA, Meyer EA, Free KE, Bondi CO, Kline AE
- Issue date: 2018 Feb 26
- Found in translation: Understanding the biology and behavior of experimental traumatic brain injury.
- Authors: Bondi CO, Semple BD, Noble-Haeusslein LJ, Osier ND, Carlson SW, Dixon CE, Giza CC, Kline AE
- Issue date: 2015 Nov